Categories Cannabis, Earnings

HEXO Corp (HEXO) likely to report weak Q1 earnings on Dec 16

HEXO Corp (TSX: HEXO; NYSE: HEXO) is slated to report its earnings results for the first quarter of 2020 on Monday, December 16, before the market opens. The top line will be benefited by cannabis sales volume as demand continues to grow for dried cannabis and cannabis oil.

However, the bottom line is likely to be hurt by costs and expenses associated with the significant increase to the scale of its operations as well as additional harvests from its greenhouses. The stock-based compensation expense, due to higher cannabis market value, could also impact the bottom line results.

Read: Aurora Cannabis Q1 earnings review

In the next ten years, the global cannabis market is expected to reach $250 billion. In the near future, 70% of the global market share will be held by a few companies and Hexo is likely to be included in the list due to its strength in the cannabis yield. Also, the company continues to explore other opportunities for analogous ventures to introduce into the cannabis market.

Analysts expect the company to post a loss of CAD0.12 per share on revenue of CAD15.75 million for the first quarter. In comparison, during the previous year quarter, Hexo posted a loss of CAD0.07 per share on revenue of CAD5.67 million.

For the fourth quarter, Hexo reported a wider loss due to higher costs and expenses despite higher revenue. The top line was driven by an 18% increase in adult-use cannabis revenue that partially offset the 12% decrease in medical cannabis revenue.

Read: Canopy Growth Q2 earnings review

Sales volume surged 45% to 4,009 kg from 2,759 kg equivalents sold in the third quarter of 2018. The company is looking for ways to expand nationally on a larger scale after establishing a strong presence within its home market of Quebec.

Also Read:  Novavax (NVAX) tops Q2 2020 bottom line targets, misses revenue views

For the first quarter of 2020, HEXO expects revenue to be in the range of CAD14 million to CAD18 million. The company estimates to achieve positive adjusted EBITDA in calendar 2020.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Novavax (NVAX) tops Q2 2020 bottom line targets, misses revenue views

Novavax (NASDAQ: NVAX) reported a loss of $17.5 million or $0.30 per share for the second quarter of 2020. Revenue jumped to $35.54 million in Q2 from $3.36 million in

Tilray Q2 loss widens despite revenue growth; results miss

https://www.youtube.com/watch?v=KqNZ-_X4F8k&t=2s Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite a marked increase in revenues. Revenues of the Canada-based company

Infographic: Duke Energy Q2 2020 Earnings Results

Duke Energy (NYSE: DUK) reported second-quarter financial results before the market opened on Monday.  The energy holding company surpassed earnings expectations by 5 cents per share during the quarter. DUK

Top